{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05376748",
            "orgStudyIdInfo": {
                "id": "00001607"
            },
            "organization": {
                "fullName": "University of Vermont",
                "class": "OTHER"
            },
            "briefTitle": "Exercise Capacity Before and After AF Ablation in Patients With HFpEF",
            "officialTitle": "Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction Before and After Ablation of Atrial Fibrillation",
            "therapeuticArea": [
                "Cardiovascular",
                "Other"
            ],
            "study": "exercise-capacity-before-and-after-af-ablation-in-patients-with-hfpef"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-04-15",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-06-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-04-25",
            "studyFirstSubmitQcDate": "2022-05-12",
            "studyFirstPostDateStruct": {
                "date": "2022-05-17",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-06-20",
            "lastUpdatePostDateStruct": {
                "date": "2023-06-22",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Nicole Habel, MD",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "University of Vermont"
            },
            "leadSponsor": {
                "name": "University of Vermont",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "In a prospective, observational pilot study of patients scheduled for an atrial fibrillation (AF) ablation at the University of Vermont Medical Center the investigators will compare exercise capacity before and four months after AF ablation.",
            "detailedDescription": "Patients \u2265 18 years of age who are scheduled for an AF ablation at the University of Vermont Medical Center will be screened for the following inclusion criteria: H2FpEF score of \u2265 6 (corresponding to \u226590% probability of HFpEF (19)) AND echocardiogram within the past 2 years that reported a LV ejection fraction \u2265 50% AND at least one symptom of HF (dyspnea on exertion, orthopnea or paroxysmal nocturnal dyspnea). Exclusion criteria: (1) Life expectancy \\<12 months, (2) moderate or more valvular disease, (3) inability to walk on a treadmill. Patients with early recurrent AF (defined as AF after a 12-week post-procedural blanking period accounting for post-ablation inflammation) will be withdrawn from the study and not proceed to the 4 month follow up visit."
        },
        "conditionsModule": {
            "conditions": [
                "Heart Failure With Preserved Ejection Fraction",
                "Atrial Fibrillation"
            ],
            "keywords": [
                "Ablation",
                "HFpEF",
                "atrial fibrillation",
                "exercise capacity",
                "peak oxygen consumption"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "bioSpec": {
                "retention": "SAMPLES_WITHOUT_DNA",
                "description": "Blood samples"
            },
            "enrollmentInfo": {
                "count": 34,
                "type": "ESTIMATED"
            }
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in peak VO2",
                    "description": "cardiopulmonary exercise testing will be performed \\& peak VO2 measured at baseline \\& follow up visit",
                    "timeFrame": "before AF ablation and 4 months after AF ablation"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in KCCQ score",
                    "description": "Kansas City Cardiomyopathy Questionnaire (KCCQ) will be obtained at baseline visit \\& again at ablation follow up visit. Scale 0-100 with higher scores signifying better quality of life.",
                    "timeFrame": "before and 4 months after AF ablation"
                },
                {
                    "measure": "Percent change in NTproBNP",
                    "description": "Initial sample taken day of AF ablation as is standard of care; reassessed at 4 month f/u visit",
                    "timeFrame": "before and 4 months after AF ablation"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Difference in peak VO2 in patient with vs. without chronic rate control",
                    "description": "4 months f/u cardiopulmonary exercise testing performance compared between those with and without chronic rate control",
                    "timeFrame": "4 months post-ablation"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* H2FpEF score of \u2265 6 (corresponding to \\>90% probability of HFpEF (19))\n* echocardiogram within the past 2 years that reported a LV ejection fraction \u2265 50%\n* at least one symptom of HF (dyspnea on exertion, orthopnea or paroxysmal nocturnal dyspnea).\n* AF ablation scheduled at UVMMC\n\nExclusion Criteria:\n\n* Life expectancy \\<12 months\n* moderate or more valvular disease\n* inability to walk on a treadmill",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "110 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "Adults with atrial fibrillation and HFpEF who are undergoing AF ablation",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Nicole Habel, MD",
                    "role": "CONTACT",
                    "phone": "8028470000",
                    "email": "nicole.habel@uvmhealth.org"
                },
                {
                    "name": "Amy Henderson",
                    "role": "CONTACT",
                    "email": "amy.henderson@uvmhealth.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Nicole Habel, MD",
                    "affiliation": "University of Vermont",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Vermont Medical Center",
                    "status": "RECRUITING",
                    "city": "Burlington",
                    "state": "Vermont",
                    "zip": "05405",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Nicole Habel, MD",
                            "role": "CONTACT",
                            "email": "nicole.habel@uvmhealth.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.47588,
                        "lon": -73.21207
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "24078336",
                    "type": "BACKGROUND",
                    "citation": "Oktay AA, Rich JD, Shah SJ. The emerging epidemic of heart failure with preserved ejection fraction. Curr Heart Fail Rep. 2013 Dec;10(4):401-10. doi: 10.1007/s11897-013-0155-7."
                },
                {
                    "pmid": "7594087",
                    "type": "BACKGROUND",
                    "citation": "Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol. 1995 Dec;26(7):1565-74. doi: 10.1016/0735-1097(95)00381-9."
                },
                {
                    "pmid": "16855265",
                    "type": "BACKGROUND",
                    "citation": "Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006 Jul 20;355(3):251-9. doi: 10.1056/NEJMoa052256."
                },
                {
                    "pmid": "21737017",
                    "type": "BACKGROUND",
                    "citation": "Haykowsky MJ, Brubaker PH, John JM, Stewart KP, Morgan TM, Kitzman DW. Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction. J Am Coll Cardiol. 2011 Jul 12;58(3):265-74. doi: 10.1016/j.jacc.2011.02.055."
                },
                {
                    "pmid": "31744334",
                    "type": "BACKGROUND",
                    "citation": "Mikkelsen N, Cadarso-Suarez C, Lado-Baleato O, Diaz-Louzao C, Gil CP, Reeh J, Rasmusen H, Prescott E. Improvement in VO2peak predicts readmissions for cardiovascular disease and mortality in patients undergoing cardiac rehabilitation. Eur J Prev Cardiol. 2020 May;27(8):811-819. doi: 10.1177/2047487319887835. Epub 2019 Nov 19."
                },
                {
                    "pmid": "22773109",
                    "type": "BACKGROUND",
                    "citation": "Swank AM, Horton J, Fleg JL, Fonarow GC, Keteyian S, Goldberg L, Wolfel G, Handberg EM, Bensimhon D, Illiou MC, Vest M, Ewald G, Blackburn G, Leifer E, Cooper L, Kraus WE; HF-ACTION Investigators. Modest increase in peak VO2 is related to better clinical outcomes in chronic heart failure patients: results from heart failure and a controlled trial to investigate outcomes of exercise training. Circ Heart Fail. 2012 Sep 1;5(5):579-85. doi: 10.1161/CIRCHEARTFAILURE.111.965186. Epub 2012 Jul 6."
                },
                {
                    "pmid": "29089342",
                    "type": "BACKGROUND",
                    "citation": "Nadruz W Jr, West E, Sengelov M, Santos M, Groarke JD, Forman DE, Claggett B, Skali H, Shah AM. Prognostic Value of Cardiopulmonary Exercise Testing in Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction. J Am Heart Assoc. 2017 Oct 31;6(11):e006000. doi: 10.1161/JAHA.117.006000."
                },
                {
                    "pmid": "32854840",
                    "type": "BACKGROUND",
                    "citation": "Reddy YNV, Obokata M, Verbrugge FH, Lin G, Borlaug BA. Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation. J Am Coll Cardiol. 2020 Sep 1;76(9):1051-1064. doi: 10.1016/j.jacc.2020.07.009."
                },
                {
                    "pmid": "29089343",
                    "type": "BACKGROUND",
                    "citation": "Elshazly MB, Senn T, Wu Y, Lindsay B, Saliba W, Wazni O, Cho L. Impact of Atrial Fibrillation on Exercise Capacity and Mortality in Heart Failure With Preserved Ejection Fraction: Insights From Cardiopulmonary Stress Testing. J Am Heart Assoc. 2017 Oct 31;6(11):e006662. doi: 10.1161/JAHA.117.006662."
                },
                {
                    "pmid": "26764059",
                    "type": "BACKGROUND",
                    "citation": "Anderson L, Oldridge N, Thompson DR, Zwisler AD, Rees K, Martin N, Taylor RS. Exercise-Based Cardiac Rehabilitation for Coronary Heart Disease: Cochrane Systematic Review and Meta-Analysis. J Am Coll Cardiol. 2016 Jan 5;67(1):1-12. doi: 10.1016/j.jacc.2015.10.044."
                },
                {
                    "pmid": "19351941",
                    "type": "BACKGROUND",
                    "citation": "O'Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, Leifer ES, Kraus WE, Kitzman DW, Blumenthal JA, Rendall DS, Miller NH, Fleg JL, Schulman KA, McKelvie RS, Zannad F, Pina IL; HF-ACTION Investigators. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009 Apr 8;301(14):1439-50. doi: 10.1001/jama.2009.454."
                },
                {
                    "pmid": "10069785",
                    "type": "BACKGROUND",
                    "citation": "Belardinelli R, Georgiou D, Cianci G, Purcaro A. Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome. Circulation. 1999 Mar 9;99(9):1173-82. doi: 10.1161/01.cir.99.9.1173."
                },
                {
                    "pmid": "31908127",
                    "type": "BACKGROUND",
                    "citation": "Tamargo M, Obokata M, Reddy YNV, Pislaru SV, Lin G, Egbe AC, Nishimura RA, Borlaug BA. Functional mitral regurgitation and left atrial myopathy in heart failure with preserved ejection fraction. Eur J Heart Fail. 2020 Mar;22(3):489-498. doi: 10.1002/ejhf.1699. Epub 2020 Jan 7."
                },
                {
                    "pmid": "29024227",
                    "type": "BACKGROUND",
                    "citation": "Kaye DM, Silvestry FE, Gustafsson F, Cleland JG, van Veldhuisen DJ, Ponikowski P, Komtebedde J, Nanayakkara S, Burkhoff D, Shah SJ. Impact of atrial fibrillation on rest and exercise haemodynamics in heart failure with mid-range and preserved ejection fraction. Eur J Heart Fail. 2017 Dec;19(12):1690-1697. doi: 10.1002/ejhf.930. Epub 2017 Oct 11."
                },
                {
                    "pmid": "32488748",
                    "type": "BACKGROUND",
                    "citation": "Fukasawa K, Fukuda K, Mori N, Kondo M, Chiba T, Miki K, Hasebe Y, Nakano M, Shimokawa H. Impacts of sinus rhythm maintenance with catheter ablation on exercise tolerance in patients with paroxysmal atrial fibrillation. J Interv Card Electrophysiol. 2021 Jun;61(1):105-113. doi: 10.1007/s10840-020-00786-y. Epub 2020 Jun 1."
                },
                {
                    "pmid": "27029350",
                    "type": "BACKGROUND",
                    "citation": "Di Biase L, Mohanty P, Mohanty S, Santangeli P, Trivedi C, Lakkireddy D, Reddy M, Jais P, Themistoclakis S, Dello Russo A, Casella M, Pelargonio G, Narducci ML, Schweikert R, Neuzil P, Sanchez J, Horton R, Beheiry S, Hongo R, Hao S, Rossillo A, Forleo G, Tondo C, Burkhardt JD, Haissaguerre M, Natale A. Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial. Circulation. 2016 Apr 26;133(17):1637-44. doi: 10.1161/CIRCULATIONAHA.115.019406. Epub 2016 Mar 30."
                },
                {
                    "pmid": "29385358",
                    "type": "BACKGROUND",
                    "citation": "Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, Merkely B, Pokushalov E, Sanders P, Proff J, Schunkert H, Christ H, Vogt J, Bansch D; CASTLE-AF Investigators. Catheter Ablation for Atrial Fibrillation with Heart Failure. N Engl J Med. 2018 Feb 1;378(5):417-427. doi: 10.1056/NEJMoa1707855."
                },
                {
                    "pmid": "29792299",
                    "type": "BACKGROUND",
                    "citation": "Reddy YNV, Carter RE, Obokata M, Redfield MM, Borlaug BA. A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction. Circulation. 2018 Aug 28;138(9):861-870. doi: 10.1161/CIRCULATIONAHA.118.034646."
                },
                {
                    "pmid": "20852060",
                    "type": "BACKGROUND",
                    "citation": "Kitzman DW, Brubaker PH, Morgan TM, Stewart KP, Little WC. Exercise training in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial. Circ Heart Fail. 2010 Nov;3(6):659-67. doi: 10.1161/CIRCHEARTFAILURE.110.958785. Epub 2010 Sep 17."
                },
                {
                    "type": "BACKGROUND",
                    "citation": "Sugumar H, Nanayakkara S, Vizi D, Chieng D, Leet A, Mariani J, Taylor A, Kalman J, Kistler P, Ling L. Impact of catheter ablation on HFpEF in people with comorbid atrial fibrillation and HFpEF using invasive haemodynamic testing. European Heart Journal. 2020; 41(2): ehaa946.0892."
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "UNDECIDED"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000006333",
                    "term": "Heart Failure"
                },
                {
                    "id": "D000001281",
                    "term": "Atrial Fibrillation"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006331",
                    "term": "Heart Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000001145",
                    "term": "Arrhythmias, Cardiac"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9421",
                    "name": "Heart Failure",
                    "asFound": "Heart Failure",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4586",
                    "name": "Atrial Fibrillation",
                    "asFound": "Atrial Fibrillation",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9419",
                    "name": "Heart Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M4453",
                    "name": "Arrhythmias, Cardiac",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        }
    },
    "hasResults": false
}